Event Details

Join Immatics at the 15th Annual PEGS Europe Summit! Industry leaders will be discussing translational approaches and optimization of candidates so they can advance them to the growing repertoire of successful bispecific antibody therapeutics that are FDA-approved and on the market.

Wednesday, November 15, 9:30 - 10:00 AM (CET)

• Session: Translational Approaches to Optimizing Dosing
• Speaker: Fabian Richter, Director TCR Discovery, Immatics Biotechnologies
• Presentation: TCER Development: Safety Aspects from Discovery to Lead Candidate

Thursday, November 16, 3:50 - 4:20 PM (CET)

• Session: Effector Cell Redirection
• Speaker: Felix Unverdorben, Associate Director TCR Engineering & Bispecifics, Immatics Biotechnologies
• Presentation: TCER: Next-Generation, Half-Life Extended TCR Bispecifics Designed to Maximize Efficacy while Minimizing Toxicities for Patients

We are looking forward to meeting you!

For more information visit the event's homepage.